Bimzelx (bimekizumab-bkzx)

Bimzelx (bimekizumab-bkzx) is a prescription medicine for the treatment of adult patients with plaque psoriasis, who are candidates for systemic therapy or phototherapy.

Bimzelx (bimekizumab-bkzx) is approved by the FDA in the USA and the EMA in Europe.

  • Disease Indications : Psoriasis
  • Usage : Subcutaneous
Medicine approved by
  • European Medical Agency (EMA)
  • Food and Drug Administration (FDA)